TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

GMP Drug Substance Market to Reach USD 4.64 Billion by 2034, Growing at 6.14% CAGR

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Towards Healthcare
GMP Drug Substance Market to Reach USD 4.64 Billion by 2034, Growing at 6.14% CAGR

The global GMP drug substance market is projected to grow from $2.71 billion in 2025 to $4.64 billion by 2034, with a 6.14% CAGR. North America dominates the market, driven by advanced manufacturing infrastructure and increasing demand for biologics and complex therapies.

Insights
META   negative

Stock plunged 10% after announcing massive AI-related capital spending


LZAGY   positive

Leading global CDMO with comprehensive biologics and small molecule services, positioned well in a growing market